Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001197350-26-000006

CHIEF FINANCIAL OFFICER sold 7,287 shares at $91.98 ($670,243)

  • CHIEF FINANCIAL OFFICER acquired 13,334 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BJERKHOLT ERIC · CHIEF FINANCIAL OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-15 Exercise or conversion : show line 1 in the form +13,334 57,075 D
2026-03-16 Sale : show line 2 in the form −7,287 $91.98 $670,243 49,788 D
Open-market sales · 7,287 sh · avg $91.98 · $670,243

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-15 Exercise or conversion : show line 3 in the form Performance Restricted Stock Units −13,334 6,666 D
Loading xslF345X05/form4-03172026_070311.xml…